Eli Lilly s Branchburg, New Jersey, plant that makes a COVID antibody treatment is the subject of a Justice Department investigation, which was launched after workers document falsification claims.
A week before Eli Lilly (LLY.N) disclosed to regulators that the U.S. Justice Department was investigating its New Jersey factory, the drugmaker told employees that its own inquiry, led by an outside law firm, found no evidence of wrongdoing there, according to a company memo reviewed by Reuters.
Read more about Eli Lilly memo says firm did not make false statements to FDA on Business Standard. (Reuters) - A week before Eli Lilly disclosed to regulators that the U.S. Justice Department was investigating its New Jersey factory, the drugmaker told employees that its own inquiry, led by an outside law firm, found no evidence of wrongdoing
Advertisement
HOME > BUSINESS >Special Report: Insider alleges Eli Lilly blocked her efforts to sound alarms about U.S. drug factory
Special Report: Insider alleges Eli Lilly blocked her efforts to sound alarms about U.S. drug factory
Reuters | Mar 11, 2021 05:31 PM EST
An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, (Photo : REUTERS/Mike Segar)
On a chilly spring morning in 2019, Amrit Mula arrived in her office at pharmaceutical giant Eli Lilly and Co s factory in Branchburg, New Jersey, to find a desk drawer open that she had kept locked. Her files were missing.